Annals of Surgical Oncology

, Volume 10, Issue 8, pp 876–881 | Cite as

Intratumoral Heterogeneity in Microsatellite Alterations in BRCA1 and PTEN Regions in Sporadic Colorectal Cancer

  • Jose M. Garcia
  • Rufo Rodriguez
  • Javier Silva
  • Concepción Muñoz
  • Gemma Dominguez
  • Jose M. Silva
  • Enric Carcereny
  • Mariano Provencio
  • Pilar España
  • Félix BonillaEmail author
Original Articles


Background: Chromosome regions 17q21 (BRCA1) and 10q23 (PTEN) have been found deleted in colorectal cancer.

Methods: We studied the frequency of loss of heterozygosity (LOH) in these 2 regions in 214 patients with only 1 sample per tumor and in 100 patients with several samples per tumor. Three microsatellite markers of each region were used for the LOH test. The polymerase chain reaction product was electrophoresed in 8% polyacrylamide gels, and band intensity was shown by silver staining.

Results: The proportions of LOH in the two regions were 38.4% for 17q21 and 30.8% for 10q23 in the group of 214 and were 47.7% for 17q21 and 34.7% for 10q23 in the group of 110434_2003_Article_876. We found a high correlation between the LOH in both regions (P < .001), where 81% of LOH in 10q23 region was matched by concomitant LOH in 17q21. In the group of tumors with several samples (group of 100), 39% and 68% did not present LOH in the 17q21 and 10q23 regions, respectively, in all of their tumor samples. However, in the 20 patients with LOH in both regions in the group of 100 (several samples per tumor), all samples with LOH in 10q23 also had LOH in 17q21, whereas not all samples with LOH in 17q21 had LOH in 10q23.

Conclusions: These results show that colorectal cancer is highly heterogeneous, at least for these tumors markers, and suggest a sequential acquisition pattern of these anomalies during tumor growth, in which changes in 17q21 could occur before those in 10q23.

Key Words

Colorectal cancer LOH BRCA1 PTEN Tumor heterogeneity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watanabe T, Wu T-T, Catalano PJ, et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001;344:1196–206.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Diep CB, Thorstensen L, Meling GI, Skovlund E, Rognum TO, Lothe RA. Genetic tumor markers with prognostic impact in Dukes’ stages B and C colorectal cancer patients. J Clin Oncol 2003;21:820–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Martinez-Lopez E, Abad A, Font A, et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998;114:1180–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Solomon E, Voss R, Hall V, et al. Chromosome 5 allele loss in human colorectal carcinomas. Nature 1987;328:616–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Ashton-Rickardt PG, Dunlop MG, Nakamura Y, et al. High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21–22. Oncogene 1989;4:1169–74.PubMedGoogle Scholar
  6. 6.
    Silva JM, Gonzalez R, Provencio M, et al. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res Treat 1999;53:9–17.CrossRefPubMedGoogle Scholar
  7. 7.
    Gao X, Zacharek A, Grignon DJ, Sakr W, Porter AT, Honn KV. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 1995;55:1002–5.PubMedGoogle Scholar
  8. 8.
    Mori T, Aoki T, Matsubara T, et al. Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. Cancer Res 1994;54:1638–40.PubMedGoogle Scholar
  9. 9.
    García-Patiño E, Gomendio B, Lleonart M, et al. Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer. Cancer Genet Cytogenet 1998;104:119–23.CrossRefPubMedGoogle Scholar
  10. 10.
    Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999;91:1922–32.CrossRefPubMedGoogle Scholar
  11. 11.
    Porter DE, Cohen BB, Wallace MR, et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutations in families linked to BRCA1 on chromosome 17q12–21. Br J Surg 1994;81:1512–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Ford D, Easton D, Bishop D, Narod S, Goldgard D Breast Cancer Research Linkage Consortium. Risk of cancer in BRCA1-mutation carriers. Lancet 1994;343:692–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Cropp CS, Nevanlinna HA, Pyrhonen S, et al. Evidence for involvement of BRCA1 in sporadic breast carcinoma. Cancer Res 1994;54:2548–51.PubMedGoogle Scholar
  14. 14.
    Wang ZJ, Taylor F, Churchman M, Norbury G, Tomlinson I. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol 1998;153:363–6.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Frayling IM, Bodmer WF, Tomlinson IP. Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. Cancer Genet Cytogenet 1997;97:64–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Li DM, Sun HI. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997;57:2130–6.Google Scholar
  17. 17.
    Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356–62.CrossRefPubMedGoogle Scholar
  18. 18.
    Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Liaw D, Mash DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden’s disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Chi SG, Kim HJ, Park BJ, et al. Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease. Gastroenterology 1998;115:1084–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Guanti G, Resta N, Simone C, et al. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet 2000;9:283–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Dicuonzo G, Angeletti S, Garcia-Foncillas J, et al. Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res 2001;12:4049–53.Google Scholar
  23. 23.
    Chapman MS, Verma IM. Transcriptional activation by BRCA1. Nature 1996;382:678–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997;88:265–75.CrossRefPubMedGoogle Scholar
  25. 25.
    Ouchi T, Monteiro ANA, August A, Aaronson SA, Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A 1998;95:2302–6.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995;11:428–33.CrossRefPubMedGoogle Scholar
  27. 27.
    Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1997;57:4420–6.PubMedGoogle Scholar
  28. 28.
    Vasen HF, Macklin JP, Meera-Khan P, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–5.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Smith TM, Lee MK, Szabo CI, et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996;6:1029–49.CrossRefPubMedGoogle Scholar
  30. 30.
    García JM, Silva JM, Dominguez G, et al. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 1999;57:237–43.CrossRefPubMedGoogle Scholar
  31. 31.
    Kinzler KW, Vogelstein B. Gatekeepers and caretakers. Nature 1997;386:761–3.CrossRefPubMedGoogle Scholar
  32. 32.
    García JM, Silva JM, Dominguez G, Silva J, Bonilla F. Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations. Genes Chromosomes Cancer 2001;31:300–301.CrossRefPubMedGoogle Scholar
  33. 33.
    Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987;238:193–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247–54.CrossRefPubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2003

Authors and Affiliations

  • Jose M. Garcia
    • 1
  • Rufo Rodriguez
    • 2
  • Javier Silva
    • 1
  • Concepción Muñoz
    • 3
  • Gemma Dominguez
    • 1
  • Jose M. Silva
    • 1
  • Enric Carcereny
    • 1
  • Mariano Provencio
    • 1
  • Pilar España
    • 1
  • Félix Bonilla
    • 1
    • 4
    Email author
  1. 1.Department of Medical OncologyHospital Universitario Puerta de HierroMadridSpain
  2. 2.Department of PathologyHospital Virgen de la SaludToledoSpain
  3. 3.Department of GastroenterologyHospital Virgen de la SaludToledoSpain
  4. 4.Department of Medical OncologyHospital Universitario Puerta de HierroE-28035 MadridSpain

Personalised recommendations